Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California, Massachusetts Bills Propose Ban On DEHP In Medical Devices

This article was originally published in The Gray Sheet

Executive Summary

C.R. Bard and Kendall Healthcare's lines of Foley urinary catheters may receive increased exposure in California and Massachusetts if the states pass legislation banning the use of DEHP, a chemical used to soften polyvinyl chloride (PVC) plastic, in medical devices

You may also be interested in...



PVC Safety Concerns Reflected Too Broadly In FDA Guidance, Industry Asserts

FDA's draft guidance on DEHP-plasticized polyvinyl chloride is incompatible with the agency's safety assessment and should be withdrawn, health product manufacturers contend

PVC Draft Guidance Advises DEHP Caution, Eschews Labeling Requirement

Polyvinylchloride (PVC) devices made with the plasticizer DEHP will not usually require new 510(k)s or PMA supplements for substitution of materials, FDA clarifies in a Sept. 6 draft guidance

PVC/DEHP Public Health Notice Offers Alternatives For High-Risk Procedures

FDA has followed recommendations from Health Care Without Harm by listing several alternatives to PVC/DEHP devices for high-risk procedures, as well as an informational website, in a July 12 public health notification issued to health provider groups

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel